Skip to main content

Pharmacopeial Forum Table of Contents

View the current Pharmacopeial Forum (PF) Table of Contents. Forolder PF tables of contents, visit our archive.

Select from the below links to access PF content. A free resource, PF visitors mustcreate a user name and password.

PF 47(5) Table of Contents Publish date: [Sep 1, 2021]

Proposed Interim Revision Announcements

USP Monographs

Carbidopa and Levodopa Tablets 1-MAR-2022

Loperamide Hydrochloride 1-MAR-2022

Methotrexate 1-MAR-2022

Dietary Supplement Monograph

Selenomethionine 1-MAR-2022

In-Process Revision

General Tests and Assays Chapters

<313> Molecular Weight and Polymer Chain Length Determination for Polypropylene Glycol Fatty Ethers [NEW] (USPNF 2023 ISSUE 1)

<314> Molecular Weight Determination for Copolymers Containing Alkyl Methacrylate or Alkyl Acrylate [NEW] (USPNF 2023 ISSUE 1)

<432> Determination of Zeta Potential by Electrophoretic Light Scattering (USPNF 2023 ISSUE 1)

General Information Chapters

<1083> Supplier Qualification [NEW] (USPNF 2023 ISSUE 1)

<1229.19> Simultaneous Decontamination and Sterilization [NEW] (USPNF 2023 ISSUE 1)

<1229.20> Decontamination and Sterilization Pre, Mid and Post Process-Considerations [NEW] (USPNF 2023 ISSUE 1)

Dietary Supplement Chapter

<2800> Multi-Ingredient Dietary Supplement Products - Development of Quality Tests [NEW] (USPNF 2023 ISSUE 1)

Reagents, Indicators, and Solutions

Reagent Specifications

Methanol (USPNF 2023 ISSUE 1)

Tetrahydrofuran (USPNF 2023 ISSUE 1)

Test Solutions

25% Phosphoric Acid TS [NEW] (USPNF 2023 ISSUE 1)

Volumetric Solutions

0.5 N Sodium Methoxide in Methanol VS (USPNF 2023 ISSUE 1)

0.1 N Sodium Methoxide in Toluene VS (USPNF 2023 ISSUE 1)

Chromatographic Columns

G52 [NEW] (USPNF 2023 ISSUE 1)

Reference Tables

Description and Solubility (USPNF 2023 ISSUE 1)

USP Monographs

Aloe (USPNF 2023 ISSUE 1)

Amphetamine Sulfate Tablets (USPNF 2023 ISSUE 1)

Artemether [NEW] (USPNF 2023 ISSUE 1)

Artemether and Lumefantrine Tablets [NEW] (USPNF 2023 ISSUE 1)

Bemotrizinol [NEW] (USPNF 2023 ISSUE 1)

Chlorthalidone (USPNF 2023 ISSUE 1)

Chlorthalidone Tablets (USPNF 2023 ISSUE 1)

Clonidine Hydrochloride Tablets (USPNF 2023 ISSUE 1)

Cyclophosphamide Capsules [NEW] (USPNF 2023 ISSUE 1)

Dextran 40 (USPNF 2023 ISSUE 1)

Dimethyl Fumarate [NEW] (USPNF 2023 ISSUE 1)

Dimethyl Fumarate Delayed-Release Capsules [NEW] (USPNF 2023 ISSUE 1)

Dopamine Hydrochloride Injection (USPNF 2023 ISSUE 1)

Doxycycline for Oral Suspension (USPNF 2023 ISSUE 1)

Ethacrynic Acid Tablets (USPNF 2023 ISSUE 1)

Etodolac (USPNF 2023 ISSUE 1)

Etodolac Tablets (USPNF 2023 ISSUE 1)

Gabapentin Compounded Cream [NEW] (USPNF 2023 ISSUE 1)

Ganciclovir for Injection (USPNF 2023 ISSUE 1)

Hydrocortisone Compounded Oral Suspension [NEW] (USPNF 2023 ISSUE 1)

Isosorbide Mononitrate Extended-Release Tablets (USPNF 2023 ISSUE 1)

Ketotifen Fumarate [NEW] (USPNF 2023 ISSUE 1)

Manganese Sulfate Injection (USPNF 2023 ISSUE 1)

Parachlorophenol (USPNF 2023 ISSUE 1)

Polyvinyl Alcohol (USPNF 2023 ISSUE 1)

Risedronate Sodium Delayed-Release Tablets [NEW] (USPNF 2023 ISSUE 1)

Roflumilast (USPNF 2023 ISSUE 1)

Terbutaline Sulfate (USPNF 2023 ISSUE 1)

Terbutaline Sulfate Injection (USPNF 2023 ISSUE 1)

Trazodone Hydrochloride Tablets (USPNF 2023 ISSUE 1)

Triclabendazole [NEW] (USPNF 2023 ISSUE 1)

Valsartan Tablets (USPNF 2023 ISSUE 1)

Dietary Supplement Monographs

Bifidobacterium animalis subsp. lactis (USPNF 2023 ISSUE 1)

Bitter Orange Young Fruit [NEW] (USPNF 2023 ISSUE 1)

Bitter Orange Young Fruit Powder [NEW] (USPNF 2023 ISSUE 1)

Curcuminoids Capsules (USPNF 2023 ISSUE 1)

Curcuminoids Tablets (USPNF 2023 ISSUE 1)

Neem Leaf [NEW] (USPNF 2023 ISSUE 1)

Neem Leaf Dry Extract [NEW] (USPNF 2023 ISSUE 1)

Neem Leaf Powder [NEW] (USPNF 2023 ISSUE 1)

NF Monograph

Polypropylene Glycol 11 Stearyl Ether (USPNF 2023 ISSUE 1)